Suppr超能文献

一篇关于指导老年人减药的证据的叙述性综述。

A narrative review of evidence to guide deprescribing among older adults.

作者信息

Ie Kenya, Aoshima Shuichi, Yabuki Taku, Albert Steven M

机构信息

Division of General Internal Medicine Department of Internal Medicine St. Marianna University School of Medicine Kawasaki Japan.

Division of General Internal Medicine Department of Internal Medicine Kawasaki Municipal Tama Hospital Kawasaki Japan.

出版信息

J Gen Fam Med. 2021 May 28;22(4):182-196. doi: 10.1002/jgf2.464. eCollection 2021 Jul.

Abstract

Potentially inappropriate prescription and polypharmacy are well-known risk factors for morbidity and mortality among older adults. However, recent systematic reviews have failed to demonstrate the overall survival benefits of deprescribing. Thus, it is necessary to synthesize the current evidence to provide a practical direction for future research and clinical practice. This review summarizes the existing body of evidence regarding deprescribing to identify useful intervention elements. There is evidence that even simple interventions, such as direct deprescribing targeted at risky medications and explicit criteria-based approaches, effectively reduce inappropriate prescribing. On the other hand, if the goal is to improve clinical outcomes such as hospitalization and emergency department visits, patient-centered multimodal interventions such as a combination of medication review, multidisciplinary collaboration, and patient education are likely to be more effective. We also consider the opportunities and challenges for deprescribing within the Japanese healthcare system.

摘要

潜在不适当处方和多重用药是老年人发病和死亡的众所周知的风险因素。然而,最近的系统评价未能证明减药对总体生存的益处。因此,有必要综合当前证据,为未来研究和临床实践提供实用指导。本综述总结了关于减药的现有证据,以确定有用的干预要素。有证据表明,即使是简单的干预措施,如针对高风险药物的直接减药和基于明确标准的方法,也能有效减少不适当处方。另一方面,如果目标是改善住院和急诊就诊等临床结局,以患者为中心的多模式干预措施,如药物审查、多学科协作和患者教育相结合,可能会更有效。我们还考虑了日本医疗体系中减药的机遇和挑战。

相似文献

1
A narrative review of evidence to guide deprescribing among older adults.
J Gen Fam Med. 2021 May 28;22(4):182-196. doi: 10.1002/jgf2.464. eCollection 2021 Jul.
2
Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions.
Int J Gen Med. 2021 Jul 24;14:3793-3807. doi: 10.2147/IJGM.S253177. eCollection 2021.
4
The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Drugs Aging. 2018 Nov;35(11):973-984. doi: 10.1007/s40266-018-0593-8.
5
Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.
J Am Med Dir Assoc. 2019 Mar;20(3):362-372.e11. doi: 10.1016/j.jamda.2018.10.026. Epub 2018 Dec 21.
6
Deprescribing medications in older people: a narrative review.
Drugs Today (Barc). 2018 Aug;54(8):489-498. doi: 10.1358/dot.2018.54.8.2856495.
7
Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.
Ann Pharmacother. 2015 Jan;49(1):29-38. doi: 10.1177/1060028014558290. Epub 2014 Nov 10.
9
Deprescribing in older people.
Maturitas. 2016 Sep;91:115-34. doi: 10.1016/j.maturitas.2016.06.006. Epub 2016 Jun 18.
10
Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Int J Clin Pharm. 2019 Feb;41(1):159-166. doi: 10.1007/s11096-018-0753-2. Epub 2018 Nov 27.

引用本文的文献

3
A Pathway to Healthier Aging or an Illusion? A Narrative Review on Deprescribing Protocols for the Elderly.
Sage Open Aging. 2025 Jun 9;11:30495334251345091. doi: 10.1177/30495334251345091. eCollection 2025 Jan-Dec.
4
Development of a Japanese version of the patient perceptions of deprescribing - Short form.
J Gen Fam Med. 2024 Oct 6;26(1):45-53. doi: 10.1002/jgf2.733. eCollection 2025 Jan.
6
Medication Optimization Protocol Efficacy for Geriatric Inpatients: A Randomized Clinical Trial.
JAMA Netw Open. 2024 Jul 1;7(7):e2423544. doi: 10.1001/jamanetworkopen.2024.23544.

本文引用的文献

2
Standards in medication review: An international perspective.
Can Pharm J (Ott). 2020 Jul 14;153(4):215-223. doi: 10.1177/1715163520929665. eCollection 2020 Jul-Aug.
3
The impact of decreasing potentially inappropriate medications on activities of daily living in a convalescent rehabilitation setting.
Int J Clin Pharm. 2021 Jun;43(3):577-585. doi: 10.1007/s11096-020-01165-3. Epub 2020 Nov 2.
8
Drug deprescription-withdrawal risk, prevention, and treatment.
Proc (Bayl Univ Med Cent). 2019 Dec 20;33(2):213-217. doi: 10.1080/08998280.2019.1695510. eCollection 2020 Apr.
9
The effect of inpatient pharmaceutical care on nephrotic syndrome patients after discharge: a randomized controlled trial.
Int J Clin Pharm. 2020 Apr;42(2):617-624. doi: 10.1007/s11096-020-00975-9. Epub 2020 Mar 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验